NNVC logo

NanoViricides (NNVC) Operating Profit

Annual Operating Profit

-$8.52 M
+$427.40 K+4.78%

June 30, 2024

Summary

Performance

1-Year Change

+4.78%

3-Year Change

+2.61%

5-Year Change

+1.66%

15-Year Change

+11.3%

NNVC Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

69.39%
NNVC annual operating income is higher than 69.39% of companies in Healthcare sector

High & Low

All-time High

-$66.00 K

3-Year Low

-$8.94 M

Earnings dates

Last Annual Earnings Report Date

Jun 30, 2024
NNVC previous annual earnings announcement was published on Jun 30, 2024

Next Annual Earnings Report Date

N/A
NNVC next annual earnings announcement has not yet been scheduled

OtherNNVCprofitabilitymetrics:

Annual Operating Margin

-
NNVC annual operating profit margin value is unknown

Annual Revenue

-
NNVC annual revenue value is unknown

Annual Net Income

-$8.29 M
NNVC annual net profit is -$8.29 million

Annual EPS

-$0.70
NNVC annual earnings per share is -$0.70

Quarterly Operating Profit

-$2.06 M
+$1.11 M+35.00%

December 31, 2024

Summary

Performance

3-Month Change

+35%

1-Year Change

+35%

3-Year Change

+35%

5-Year Change

+35%

NNVC Quarterly Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

66.1%
NNVC quarterly operating income is higher than 66.1% of companies in Healthcare sector

High & Low

All-time High

-$405.20 K

3-Year Low

-$3.68 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
NNVC previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 15, 2025
NNVC next earnings announcement is scheduled for May 15, 2025

OtherNNVCprofitabilitymetrics:

Quarterly Operating Margin

-
NNVC quarterly operating profit margin value is unknown

Quarterly Revenue

-
NNVC quarterly revenue value is unknown

Quarterly Net Income

-$2.03 M
NNVC quarterly net profit is -$2.03 million

Quarterly EPS

-$0.14
NNVC quarterly earnings per share is -$0.14

TTM Operating Profit

-$9.53 M
+$125.70 K+1.30%

December 31, 2024

Summary

Performance

3-Month Change

+1.3%

1-Year Change

+1.3%

3-Year Change

+1.3%

5-Year Change

+1.3%

NNVC TTM Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

66.78%
NNVC TTM operating income is higher than 66.78% of companies in Healthcare sector

High & Low

All-time High

-$673.00 K

3-Year Low

-$9.80 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
NNVC previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 15, 2025
NNVC next earnings announcement is scheduled for May 15, 2025

OtherNNVCprofitabilitymetrics:

Annual Operating Margin

-
NNVC annual operating profit margin value is unknown

TTM Revenue

-
NNVC TTM revenue value is unknown

TTM Net Income

-$9.36 M
NNVC TTM net profit is -$9.36 million

TTM EPS

-$0.72
NNVC TTM earnings per share is -$0.72

Operating Profit Formula

Operating Profit = Gross Profit − Operating Expenses

Annual Operating Profit

-$8.52 M
NNVC annual operating income is -$8.52 million

Annual Gross Profit

-
NNVC annual gross profit value is unknown

Annual Operating Expenses

$8.52 M
NNVC annual total operating expenses is $8.52 million

NNVC Operating Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+4.8%+35.0%+1.3%
3 y3 years+2.6%+35.0%+1.3%
5 y5 years+1.7%+35.0%+1.3%

NNVC Operating Profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-5.0%+4.8%-26.9%+44.0%-35.4%+2.8%
5 y5-year-6.5%+4.8%-26.9%+44.0%-35.4%+2.8%
alltimeall time<-9999.0%+11.3%-408.2%+45.7%-1315.6%+3.3%

NanoViricides Operating Profit History

DateAnnualQuarterlyTTM
Dec 2024
-
-$2.06 M(-35.0%)
-$9.53 M(-1.3%)
Sep 2024
-
-$3.17 M(+32.5%)
-$9.65 M(+13.3%)
Jun 2024
-$8.52 M(-4.8%)
-$2.39 M(+25.3%)
-$8.52 M(-13.1%)
Mar 2024
-
-$1.91 M(-12.7%)
-$9.80 M(+1.0%)
Dec 2023
-
-$2.18 M(+7.5%)
-$9.70 M(+3.8%)
Sep 2023
-
-$2.03 M(-44.7%)
-$9.35 M(+4.6%)
Jun 2023
-$8.94 M(+10.2%)
-$3.68 M(+103.0%)
-$8.94 M(+26.7%)
Mar 2023
-
-$1.81 M(-1.3%)
-$7.06 M(+0.3%)
Dec 2022
-
-$1.83 M(+13.0%)
-$7.04 M(-1.2%)
Sep 2022
-
-$1.62 M(-9.5%)
-$7.12 M(-12.2%)
Jun 2022
-$8.11 M(-7.2%)
-$1.79 M(+0.3%)
-$8.11 M(-3.4%)
Mar 2022
-
-$1.79 M(-6.9%)
-$8.40 M(-3.7%)
Dec 2021
-
-$1.92 M(-26.5%)
-$8.71 M(-4.1%)
Sep 2021
-
-$2.61 M(+25.9%)
-$9.09 M(+3.9%)
Jun 2021
-$8.74 M(+9.3%)
-$2.07 M(-1.6%)
-$8.74 M(+2.9%)
Mar 2021
-
-$2.11 M(-8.0%)
-$8.50 M(-4.9%)
Dec 2020
-
-$2.29 M(+0.9%)
-$8.94 M(+7.9%)
Sep 2020
-
-$2.27 M(+23.9%)
-$8.28 M(+3.5%)
Jun 2020
-$8.00 M(-7.7%)
-$1.83 M(-27.9%)
-$8.00 M(-4.0%)
Mar 2020
-
-$2.54 M(+55.6%)
-$8.33 M(+5.8%)
Dec 2019
-
-$1.63 M(-17.8%)
-$7.87 M(-8.5%)
Sep 2019
-
-$1.99 M(-8.3%)
-$8.61 M(-0.6%)
Jun 2019
-$8.66 M(-7.1%)
-$2.17 M(+4.1%)
-$8.66 M(-1.3%)
Mar 2019
-
-$2.08 M(-12.1%)
-$8.77 M(-3.7%)
Dec 2018
-
-$2.37 M(+16.2%)
-$9.11 M(-0.3%)
Sep 2018
-
-$2.04 M(-10.7%)
-$9.13 M(-2.1%)
Jun 2018
-$9.33 M(-2.9%)
-$2.28 M(-5.6%)
-$9.33 M(+0.4%)
Mar 2018
-
-$2.42 M(+1.0%)
-$9.29 M(-2.1%)
Dec 2017
-
-$2.39 M(+7.3%)
-$9.49 M(+1.0%)
Sep 2017
-
-$2.23 M(-0.7%)
-$9.39 M(-2.2%)
Jun 2017
-$9.60 M(+8.4%)
-$2.25 M(-14.1%)
-$9.60 M(-2.5%)
Mar 2017
-
-$2.62 M(+13.8%)
-$9.85 M(+6.1%)
Dec 2016
-
-$2.30 M(-5.9%)
-$9.28 M(+2.3%)
Sep 2016
-
-$2.44 M(-2.2%)
-$9.07 M(+2.4%)
Jun 2016
-$8.86 M(+25.4%)
-$2.50 M(+21.9%)
-$8.86 M(-1.2%)
Mar 2016
-
-$2.05 M(-2.0%)
-$8.97 M(+11.5%)
Dec 2015
-
-$2.09 M(-6.1%)
-$8.04 M(+5.0%)
Sep 2015
-
-$2.23 M(-14.5%)
-$7.65 M(+7.6%)
DateAnnualQuarterlyTTM
Jun 2015
-$7.06 M(-18.5%)
-$2.60 M(+131.8%)
-$7.12 M(-14.3%)
Mar 2015
-
-$1.12 M(-34.1%)
-$8.31 M(-1.3%)
Dec 2014
-
-$1.70 M(+1.0%)
-$8.42 M(-0.6%)
Sep 2014
-
-$1.69 M(-55.5%)
-$8.47 M(-2.3%)
Jun 2014
-$8.67 M(+31.5%)
-$3.79 M(+207.6%)
-$8.67 M(+34.7%)
Mar 2014
-
-$1.23 M(-29.6%)
-$6.44 M(-12.9%)
Dec 2013
-
-$1.75 M(-7.3%)
-$7.39 M(+7.4%)
Sep 2013
-
-$1.89 M(+20.9%)
-$6.89 M(+4.5%)
Jun 2013
-$6.59 M(+8.4%)
-$1.56 M(-28.7%)
-$6.59 M(+0.2%)
Mar 2013
-
-$2.19 M(+76.1%)
-$6.57 M(+1.8%)
Dec 2012
-
-$1.24 M(-21.8%)
-$6.46 M(-1.4%)
Sep 2012
-
-$1.59 M(+2.8%)
-$6.55 M(+7.4%)
Jun 2012
-$6.08 M(-5.4%)
-$1.55 M(-25.5%)
-$6.10 M(+4.9%)
Mar 2012
-
-$2.08 M(+55.3%)
-$5.82 M(-7.6%)
Dec 2011
-
-$1.34 M(+17.2%)
-$6.30 M(-2.5%)
Sep 2011
-
-$1.14 M(-9.6%)
-$6.46 M(+0.5%)
Jun 2011
-$6.43 M(+30.2%)
-$1.26 M(-50.7%)
-$6.43 M(+6.7%)
Mar 2011
-
-$2.56 M(+70.6%)
-$6.02 M(+2.3%)
Dec 2010
-
-$1.50 M(+34.9%)
-$5.89 M(+10.8%)
Sep 2010
-
-$1.11 M(+29.8%)
-$5.32 M(+7.7%)
Jun 2010
-$4.94 M(+75.2%)
-$856.20 K(-64.7%)
-$4.94 M(+4.9%)
Mar 2010
-
-$2.43 M(+161.7%)
-$4.71 M(+53.1%)
Dec 2009
-
-$926.60 K(+26.6%)
-$3.08 M(+10.1%)
Sep 2009
-
-$732.10 K(+16.9%)
-$2.79 M(-0.9%)
Jun 2009
-$2.82 M(+1.0%)
-$626.40 K(-20.9%)
-$2.82 M(-11.7%)
Mar 2009
-
-$792.00 K(+22.9%)
-$3.19 M(-0.4%)
Dec 2008
-
-$644.50 K(-14.8%)
-$3.21 M(+8.1%)
Sep 2008
-
-$756.80 K(-24.2%)
-$2.97 M(+6.2%)
Jun 2008
-$2.79 M(-9.4%)
-$998.90 K(+24.0%)
-$2.79 M(+8.7%)
Mar 2008
-
-$805.30 K(+98.7%)
-$2.57 M(-4.6%)
Dec 2007
-
-$405.20 K(-30.4%)
-$2.69 M(-10.1%)
Sep 2007
-
-$582.60 K(-24.8%)
-$2.99 M(-2.9%)
Jun 2007
-$3.08 M(+18.8%)
-$774.90 K(-16.5%)
-$3.08 M(+33.6%)
Mar 2007
-
-$928.40 K(+31.4%)
-$2.31 M(+67.3%)
Dec 2006
-
-$706.60 K(+5.0%)
-$1.38 M(+105.0%)
Sep 2006
-
-$673.00 K
-$673.00 K
Jun 2006
-$2.60 M(+3833.0%)
-
-
Jun 2005
-$66.00 K
-
-

FAQ

  • What is NanoViricides annual operating income?
  • What is the all time high annual operating profit for NanoViricides?
  • What is NanoViricides annual operating profit year-on-year change?
  • What is NanoViricides quarterly operating income?
  • What is the all time high quarterly operating profit for NanoViricides?
  • What is NanoViricides quarterly operating profit year-on-year change?
  • What is NanoViricides TTM operating income?
  • What is the all time high TTM operating profit for NanoViricides?
  • What is NanoViricides TTM operating profit year-on-year change?

What is NanoViricides annual operating income?

The current annual operating profit of NNVC is -$8.52 M

What is the all time high annual operating profit for NanoViricides?

NanoViricides all-time high annual operating income is -$66.00 K

What is NanoViricides annual operating profit year-on-year change?

Over the past year, NNVC annual operating income has changed by +$427.40 K (+4.78%)

What is NanoViricides quarterly operating income?

The current quarterly operating profit of NNVC is -$2.06 M

What is the all time high quarterly operating profit for NanoViricides?

NanoViricides all-time high quarterly operating income is -$405.20 K

What is NanoViricides quarterly operating profit year-on-year change?

Over the past year, NNVC quarterly operating income has changed by +$1.11 M (+35.00%)

What is NanoViricides TTM operating income?

The current TTM operating profit of NNVC is -$9.53 M

What is the all time high TTM operating profit for NanoViricides?

NanoViricides all-time high TTM operating income is -$673.00 K

What is NanoViricides TTM operating profit year-on-year change?

Over the past year, NNVC TTM operating income has changed by +$125.70 K (+1.30%)